Cognition Therapeutics, Inc. (CGTX)
$0.88-2.22%Close
SELLCRISIS · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $79M
- Beta
- 1.79
- P/E (TTM)
- -4.90
- Short % float
- 9.27%
- Days to cover
- 16.6
- SI change
- -2.1%
- 1W
- -5.38%
- 1M
- -10.20%
- vs SPY 1W
- -6.54%
- vs SPY 1M
- -13.20%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CGTX?
- LOPJLB’s latest quantitative signal on Cognition Therapeutics, Inc. (CGTX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CGTX in?
- Cognition Therapeutics, Inc. (CGTX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Cognition Therapeutics, Inc. (CGTX) do?
- Cognition Therapeutics, Inc. is a biopharmaceutical company in the clinical stage, focused on identifying and advancing small molecule treatments. The firm's research and development efforts are primarily directed towards age-related neurodegenerative conditions affecting the central nervous system, as well as retinal disorders. Its most advanced experimental therapy is CT1812, which acts as a …